Salesforce.com (CRM) announced its second major push into the vertical software arena within a week on Wednesday, when it’s set to unveil a venture into the health care industry — a market that some contend has near-limitless growth potential and countless avenues for tech companies to pursue. Salesforce, though, isn’t straying outside its comfort zone as it makes this push. The company has geared its health care effort around a strategy that
Volatility is hurting software stocks, with Salesforce.com (CRM), Microsoft (MSFT) and a few others the best bets to ride out the turmoil, says an analyst. In a research report Monday, UBS analyst Brent Thill says that it might be a while before investors leap back into the sector, with international market sluggishness, falling oil prices and the prospect of U.S. interest rate hikes putting a dent in growth and value stocks. “We do not expect the
Pharmacy behemoth CVS (CVS) is staking a claim in the burgeoning field of health-care technology by plunging into the field of online health services, in addition to its in-store minute clinics. With the move, CVS solidifies its digital leap into health care, joining a number of established players such as Cerner (CERN) and AthenaHealth (ATHN), which specialize in electronic medical records, and the likes of Salesforce.com (CRM), which is expected